1.1.................... moves to amend H.F. No. 1217 as follows:
1.2Delete everything after the enacting clause and insert:


1.4    Section 1. [115A.1410] TITLE.
1.5Article 1 may be cited as the Minnesota Safe Drug Disposal Act of 2010.
1.6EFFECTIVE DATE.This section is effective the day following final enactment.

1.7    Sec. 2. [115A.1411] DEFINITIONS.
1.8    Subdivision 1. Scope. For the purposes of sections 115A.1410 to 115A.1420, the
1.9following terms have the meanings given.
1.10    Subd. 2. Covered product. "Covered product" means all prescription drugs and all
1.11nonprescription drugs, including both brand name and generic drugs.
1.12    Subd. 3. Controlled substance. "Controlled substance" means those substances
1.13listed in section 152.02 and those substances designated by the Minnesota State Board of
1.14Pharmacy under section 152.02, subdivisions 7, 8, and 12.
1.15    Subd. 4. Drug wholesaler. "Drug wholesaler" has the meaning given in section
1.16151.44, paragraph (b).
1.17    Subd. 5. Drugs. "Drugs" means:
1.18(1) articles recognized in the official United States pharmacopoeia, the official
1.19national formulary, the official homeopathic pharmacopoeia of the United States, or any
1.20supplement of the formulary or those pharmacopoeias;
1.21(2) substances intended for use in the diagnosis, cure, mitigation, treatment, or
1.22prevention of disease in humans or other animals;
1.23(3) substances, other than food, intended to affect the structure or any function of
1.24the body of humans or other animals; or
2.1(4) substances intended for use as a component of any substances specified in this
2.2subdivision, but not including medical devices or their component parts or accessories.
2.3    Subd. 6. Entity. "Entity" means a person other than an individual.
2.4    Subd. 7. Generic drug. "Generic drug" means a drug that is chemically identical
2.5or bioequivalent to a brand name drug in dosage form, safety, strength, route of
2.6administration, quality, performance characteristics, and intended use, though inactive
2.7ingredients may vary.
2.8    Subd. 8. Mail-back program. "Mail-back program" means a system whereby
2.9residential generators of unwanted products obtain prepaid and preaddressed mailing
2.10envelopes in which to place unwanted products for shipment to an entity that will dispose
2.11of them safely and legally.
2.12    Subd. 9. Nonprescription drug. "Nonprescription drug" means any drug that
2.13may be lawfully sold without a prescription.
2.14    Subd. 10. Person. "Person" means an individual, firm, sole proprietorship,
2.15corporation, limited liability company, general partnership, limited partnership, limited
2.16liability partnership, association, cooperative, or other legal entity, however organized.
2.17    Subd. 11. Plan. "Plan" means a plan required under section 115A.1413 that
2.18describes the manner in which a program will be provided.
2.19    Subd. 12. Prescription drug. "Prescription drug" has the meaning given in section
2.20151.44, paragraph (d).
2.21    Subd. 13. Producer. (a) "Producer" means a person who has legal ownership of the
2.22brand, brand name, or co-brand of a covered product or manufactures a generic covered
2.23product sold in Minnesota.
2.24(b) Producer does not include a retailer who:
2.25(1) puts its store label on a covered product;
2.26(2) imports a covered product branded or manufactured by a producer who meets the
2.27requirements of paragraph (a) and who has no physical presence in the United States; or
2.28(3) sells at wholesale a covered product, does not have legal ownership of the brand,
2.29and elects to fulfill the responsibilities of the producer for that product.
2.30    Subd. 14. Product stewardship organization. "Product stewardship organization"
2.31means an organization designated by a group of producers to act as an agent on behalf of
2.32each producer to operate a program in this state.
2.33    Subd. 15. Program. "Program" means a program operated by a county, a producer,
2.34a group of producers, or a product stewardship organization to collect, transport, and
2.35provide for the final disposition of unwanted products.
3.1    Subd. 16. Residential generators. "Residential generators" means single and
3.2multiple family residences and locations where drugs are unused, unwanted, discarded,
3.3or abandoned, such as hospice services, nursing homes, boarding care homes, schools,
3.4foster care, day care, and other locations where people, pets, or both reside on a temporary
3.5or permanent basis. Residential generators do not include airport security, drug seizures
3.6by law enforcement, pharmacy waste, business waste, or any other source identified
3.7by the agency as a nonresidential source.
3.8    Subd. 17. Unwanted product. "Unwanted product" means any covered product no
3.9longer wanted by its owner or that has been abandoned, discarded, or is intended to be
3.10discarded by its owner.
3.11EFFECTIVE DATE.This section is effective the day following final enactment.

3.12    Sec. 3. [115A.1412] REGISTRATION; FEE.
3.13    Subdivision 1. Requirement for sale. On or after January 1, 2011, a producer may
3.14not sell or offer for sale in this state a covered product unless the producer has filed a
3.15registration with the agency under subdivision 2 and paid a registration fee, unless the
3.16producer is exempt from the fee under subdivision 3, paragraph (c).
3.17    Subd. 2. Producer's registration. (a) A producer of covered products must, before
3.18January 1, 2011, submit a registration to the agency that includes:
3.19(1) a list of the producer's brands of drugs offered for sale in this state;
3.20(2) the name, address and contact information of a person responsible for ensuring
3.21compliance with sections 115A.1410 to 115A.1420; and
3.22(3) an estimate of the revenues from sales of covered products in this state during the
3.23previous calendar year.
3.24(b) A producer who begins to sell or offer for sale covered products in this state after
3.25January 1, 2011, and has not filed a registration under this subdivision must submit a
3.26registration to the agency within ten days of beginning to sell or offer for sale covered
3.27products.
3.28(c) A registration must be updated within 60 days after a change in the producer's
3.29brands of covered products sold or offered for sale in this state.
3.30(d) A registration is effective upon receipt by the agency and is valid until January
3.311 of each year.
3.32(e) The agency must review each registration and notify the producer of any
3.33information required by this section that is omitted from the registration. Within 30 days
3.34of receipt of a notification from the agency, the producer must submit a revised registration
3.35providing the information noted by the agency.
4.1    Subd. 3. Producer's registration fee. (a) Each producer that registers under this
4.2section must, by January 1, 2011, and each year thereafter, pay to the commissioner an
4.3annual registration fee of $....... to cover estimated agency costs to administer the program
4.4and the program costs of counties that elect to offer a program during that calendar year,
4.5unless exempted under paragraph (c). The commissioner must deposit the fee in the
4.6account established in section 115A.1416.
4.7(b) A producer who begins to sell or offer for sale covered products in this state after
4.8January 1, 2011, must pay the registration fee required by this subdivision when the
4.9producer submits a registration to the agency.
4.10(c) A producer that operates its own program under section 115A.1413 individually,
4.11or in concert with other producers, or through a product stewardship organization, is not
4.12required to pay a registration fee.
4.13EFFECTIVE DATE.This section is effective the day following final enactment.

4.14    Sec. 4. [115A.1413] UNWANTED PRODUCTS COLLECTION PROGRAM.
4.15    Subdivision 1. Program requirements. A program established under this section
4.16must:
4.17(1) accept all unwanted products presented to the program by a residential generator,
4.18regardless of the producer;
4.19(2) offer program services at no cost to a residential generator;
4.20(3) offer convenient collection options;
4.21(4) comply with applicable state and federal health, safety, controlled substance,
4.22and environmental laws, rules, and regulations regarding handling, transporting, and
4.23arranging for the final disposition of all unwanted products collected, including the
4.24required presence of law enforcement officials;
4.25(5) promote the program to residential generators, pharmacists, retailers of covered
4.26products, and health care practitioners as the proper and safe method for the final
4.27disposition of unwanted products;
4.28(6) prepare education and outreach materials that publicize the location and
4.29operation of collection locations throughout the county and disseminate them to health
4.30care facilities, pharmacies, and other interested parties. The program may also establish a
4.31Web site publicizing collection locations and program operations and a toll-free telephone
4.32number that residential generators can call to find nearby collection locations and
4.33understand how the program works; and
5.1(7) obtain written assurance from the federal Drug Enforcement Agency that the
5.2program complies with the federal Controlled Substances Act and regulations promulgated
5.3thereunder.
5.4    Subd. 2. Program plan. Each county, producer, group of producers, or product
5.5stewardship organization offering a program under this section must submit a program
5.6plan to the agency and receive the agency's approval of the plan prior to beginning to
5.7collect unwanted products. A program plan must contain:
5.8(1) contact information for the individual directing the program;
5.9(2) a description of the methods by which unwanted products from residential
5.10generators will be collected in all areas of the county, including the location of each
5.11collection site, and an explanation of how the collection system will be convenient and
5.12adequate to serve the needs of residents in both urban and rural areas;
5.13(3) a description of how the unwanted products will be safely and securely tracked
5.14and handled from collection through final disposition and the policies and procedures
5.15to be followed to ensure security and compliance with state and federal health, safety,
5.16controlled substance, and environmental laws and regulations;
5.17(4) a description of public education and outreach activities and how their
5.18effectiveness will be evaluated; and
5.19(5) a starting date when collection of unwanted products will begin.
5.20(b) Program plans must be submitted to the agency for approval. Within 90 days
5.21after receipt of a plan, the agency shall determine whether the plan complies with sections
5.22115A.1410 to 115A.1420. If it approves a plan, the agency shall notify the applicant of its
5.23approval in writing. If it rejects a plan, the agency shall notify the applicant in writing
5.24of its reasons for rejecting the plan. An applicant whose plan has been rejected by the
5.25agency must submit a revised plan to the agency within 60 days after receiving notice of
5.26the rejection.
5.27    Subd. 3. Election. The Western Lake Superior Sanitary District may elect to offer
5.28a program under this section. If it elects to offer a program, the Western Lake Superior
5.29Sanitary District has identical authority and responsibilities given to a county under
5.30sections 115A.1410 to 115A.1420 to operate a program within its legal boundaries.
5.31EFFECTIVE DATE.This section is effective the day following final enactment.

5.32    Sec. 5. [115A.1414] FINAL DISPOSITION OF UNWANTED PRODUCTS.
5.33Each county, producer, group of producers, or product stewardship organization
5.34operating a collection program under a plan that has been approved under section
6.1115A.1413 must arrange for final disposition of all unwanted products from residential
6.2generators in accord with all applicable state and federal laws.
6.3EFFECTIVE DATE.This section is effective the day following final enactment.

6.4    Sec. 6. [115A.1415] REPORTS.
6.5(a) On or before June 30, 2012, and in each subsequent year, each county, producer,
6.6group of producers, or product stewardship organization operating a program approved
6.7by the agency must prepare and submit to the agency an annual report describing the
6.8program's activities during the previous reporting period. The report must include the
6.9following:
6.10(1) the amount, by weight, of unwanted products collected from residential
6.11generators at each drop-off site and the total amount by weight collected through a
6.12mail-back program, if applicable;
6.13(2) a description of the collection system, including the location of each collection
6.14site and locations where envelopes for a mail-back program are provided, if applicable;
6.15(3) the name and location of facilities at which unwanted products were disposed
6.16of and the weight of unwanted products collected from residential generators disposed
6.17of at each facility;
6.18(4) the amount and proportion, by weight, of controlled substances collected at each
6.19drop-off site and through a mail-back program, if applicable;
6.20(5) whether policies and procedures for collecting, transporting, and the final
6.21disposition of unwanted products, as established in the plan, were followed and a
6.22description of any noncompliance;
6.23(6) whether any safety or security problems occurred during the collection,
6.24transportation, or final disposition of unwanted products and, if so, what changes have or
6.25will be made to policies, procedures, or tracking mechanisms to alleviate the problem and
6.26to improve safety and security;
6.27(7) a description of public education and outreach activities implemented, including
6.28the methodology used to evaluate the outreach and program activities; and
6.29(8) any other information that the agency may reasonably require.
6.30For the purposes of this section, "reporting period" means the period beginning
6.31January 1 and ending December 31 of the same calendar year.
6.32(b) By January 1, 2013, the agency shall submit a report to the chairs and ranking
6.33minority members of the senate and house committees with jurisdiction over solid waste
6.34policy and solid waste finance that examines options and makes recommendations
6.35regarding methods to estimate the amount of unwanted products collected and disposed of
7.1under all active plans in a program year as a proportion of the total amount of unwanted
7.2products extant in this state during that year. The report shall suggest financial and
7.3other incentives that may be offered to producers or counties to increase the proportion
7.4of unwanted products collected.
7.5EFFECTIVE DATE.This section is effective the day following final enactment.

7.6    Sec. 7. [115A.1416] ACCOUNT; APPROPRIATION.
7.7(a) The pharmaceutical waste account is created in the environmental fund. The
7.8commissioner must deposit all revenue from the fee established in section 115A.1412,
7.9subdivision 3 in the account. Any interest earned on the account must be credited to the
7.10account. Money from other sources may be credited to the account.
7.11(b) Until June 30, 2012, money in the account is annually appropriated to the
7.12commissioner for the purpose of carrying out the purposes of section 115A.1410 to
7.13115A.1420.

7.14    Sec. 8. [115A.1417] AGENCY DUTIES.
7.15(a) The agency shall administer sections 115.1410 to 115A.1420.
7.16(b) The agency shall review and approve, reject, or modify program plans submitted
7.17under section 115A.1413.
7.18(c) The agency shall manage the account established in section 115A.1416, and
7.19shall reimburse counties for reasonable program costs incurred by the counties. If the
7.20revenues in the account exceed the amount that the agency determines is necessary for
7.21efficient and effective operation and administration of the program, including any amount
7.22for contingencies, the agency must recommend to the legislature that the producer fee be
7.23lowered in order to reduce revenues collected in the subsequent program year by the
7.24estimated amount of the excess.
7.25(d) The agency shall provide on its Web site a list of all producers that have filed a
7.26complete registration and paid a registration fee to the agency and a list of all producers
7.27the agency has identified as noncompliant with sections 115A.1412 or 115A.1416.
7.28(e) The agency shall consult with counties and producers to estimate the costs of
7.29collection, transport, and final disposition of drugs, and may set maximum rates, on a per
7.30pound or other basis, at which counties can be reimbursed for program activities.
7.31(f) The agency shall provide technical assistance to counties seeking to develop a
7.32program plan or to improve an existing plan's operations, including producing a program
7.33plan template.
8.1(g) The agency shall research alternative options for the final disposition of
8.2unwanted products.
8.3EFFECTIVE DATE.This section is effective the day following final enactment.

8.4    Sec. 9. [115A.1418] OTHER COLLECTION PROGRAMS.
8.5(a) Nothing in sections 115A.1410 to 115A.1420 prohibits or restricts the operation
8.6of any program collecting, transporting, and providing for final disposition of covered
8.7products in addition to those approved by the agency under section 115A.1413 or prohibits
8.8or restricts any persons from receiving, collecting, transporting, or providing for final
8.9disposition of covered products, provided that those persons are registered with the agency
8.10under section 115A.1412 and comply with the reporting requirements under section
8.11115A.1415, paragraph (a), and all other applicable state and federal laws.
8.12(b) A county or other public agency may not require households to use public
8.13facilities to collect, transport and arrange for final disposition of covered products to the
8.14exclusion of other lawful programs available.

8.15    Sec. 10. [115A.1419] ANTICOMPETITIVE CONDUCT.
8.16(a) A producer, group of producers, or product stewardship organization that
8.17organizes a system to collect, transport, and arrange for the final disposition of unwanted
8.18products under this section is authorized to engage in anticompetitive conduct to the extent
8.19necessary to plan and implement its chosen organized collection system and is immune
8.20from liability under state laws relating to antitrust, restraint of trade, unfair trade practices,
8.21and other regulation of trade or commerce.
8.22(b) An organization of producers, an individual producer, and its officers, members,
8.23employees, and agents who cooperate with a political subdivision that organizes a system
8.24to collect, transport, and arrange for the final disposition of unwanted products under this
8.25section are authorized to engage in anticompetitive conduct to the extent necessary to plan
8.26and implement the organized collection system, provided that the political subdivision
8.27actively supervises the participation of each entity. An organization, entity, or person
8.28covered by this paragraph is immune from liability under state law relating to antitrust,
8.29restraint of trade, unfair trade practices, and other regulation of trade or commerce.

8.30    Sec. 11. [115A.1420] ENFORCEMENT.
8.31    Subdivision 1. Generally. Sections 115A.1410 to 115A.1420 shall be enforced in
8.32the manner provided by section 115.071, subdivisions 1 to 6.
9.1    Subd. 2. Producer penalties. (a) Upon first determining that a producer is offering
9.2a covered product for sale in this state but has not filed a complete registration with the
9.3agency, or has not paid a registration fee, the agency shall send the producer a written
9.4warning that the producer is in violation of section 115A.1412.
9.5(b) A producer that has not filed a complete registration or paid a registration fee
9.6to the agency and whose covered product continues to be sold in this state 60 days after
9.7receiving a written warning from the agency must be assessed a penalty of $10,000 for
9.8each calendar day that the violation continues.
9.9(c) All penalties levied under this section must be deposited into the pharmaceutical
9.10product stewardship program account established under section 115A.1416.
9.11    Subd. 3. Wholesaler penalties. (a) It is the responsibility of a drug wholesaler
9.12offering covered products for sale in this state to view the agency's Web site to determine
9.13if a producer of products the wholesaler is offering for sale in this state is in compliance
9.14with sections 115A.1412 and 115A.1416. If a drug wholesaler is unsure of the status of a
9.15producer or believes a producer is not in compliance, the drug wholesaler shall contact the
9.16agency to determine the producer's status.
9.17(b) The agency shall send a written notice to a drug wholesaler known to be selling a
9.18product in this state from a producer who is not in compliance with sections 115A.1412
9.19or 115A.1416.
9.20(c) A drug wholesaler that continues to sell a covered product from a producer
9.21that is not in compliance with sections 115A.1412 or 115A.1416 60 days after receiving
9.22a written notice from the agency must be assessed a penalty of $1,000 for each day of
9.23noncompliance.
9.24(d) All penalties levied under this section must be deposited into the pharmaceutical
9.25product stewardship program account established under section 115A.1416.
9.26EFFECTIVE DATE.This section is effective the day following final enactment.


9.28    Section 1. [144.569] HANDLING OF PHARMACEUTICAL WASTE IN
9.29HEALTH CARE FACILITIES.
9.30    Subdivision 1. Pharmaceutical waste disposal. Health care facilities licensed or
9.31regulated by the commissioner of health, including but not limited to, nursing homes,
9.32home care and hospice entities, boarding care homes, and supervised living facilities,
9.33must not destroy or dispose of any drug by flushing it into the sewer or septic system.
9.34Health care facilities licensed or regulated under chapters 144, 144A, 144D and 144G
10.1must comply with the requirements of sections 115A.1410 to 115A.1420 for the final
10.2disposition of unused or contaminated drugs.
10.3    Subd. 2. Penalty. For a violation of subdivision 1, the commissioner of health may
10.4impose a civil penalty not exceeding $10,000 for each separate violation.
10.5EFFECTIVE DATE.This section is effective January 1, 2011.

10.6    Sec. 2. Minnesota Statutes 2008, section 151.37, subdivision 6, is amended to read:
10.7    Subd. 6. Exclusion for course of employment. (a) Nothing in this chapter shall
10.8prohibit the possession of a legend drug by an employee, agent, or sales representative of
10.9a registered drug manufacturer, or an employee or agent of a registered drug wholesaler,
10.10or registered pharmacy, while acting in the course of employment.
10.11(b) Nothing in this chapter shall prohibit the following entities from possessing a
10.12legend drug for the purpose of disposing of the legend drug as pharmaceutical waste:
10.13(1) a law enforcement officer;
10.14(2) a hazardous waste transporter licensed by the Department of Transportation;
10.15(3) a facility permitted by the Minnesota Pollution Control Agency to treat, store, or
10.16dispose of hazardous waste, including household hazardous waste;
10.17(4) a facility licensed by the Minnesota Pollution Control Agency or a metropolitan
10.18county as a Very Small Quantity Generator Collection Program or a minimal generator; or
10.19(5) a county or other entity that collects, stores, transports, or disposes of a legend
10.20drug pursuant to a program plan approved by the Pollution Control Agency under section
10.21115A.1413, or to a person authorized by one of these entities to conduct one or more
10.22of these activities.
10.23EFFECTIVE DATE.This section is effective the day following final enactment.

10.24    Sec. 3. Minnesota Statutes 2008, section 151.37, subdivision 7, is amended to read:
10.25    Subd. 7. Exclusion for prescriptions. (a) Nothing in this chapter shall prohibit the
10.26possession of a legend drug by a person for that person's use when it has been dispensed to
10.27the person in accordance with a written or oral valid prescription issued by a practitioner.
10.28(b) Nothing in this chapter shall prohibit a person, for whom a legend drug has
10.29been dispensed in accordance with a written or oral prescription by a practitioner, from
10.30designating a family member, caregiver, or other individual to handle the legend drug for
10.31the purpose of assisting the person in obtaining or administering the drug, or sending
10.32the drug for destruction.
11.1(c) Nothing in this chapter shall prohibit a person for whom a prescription drug has
11.2been dispensed in accordance with a valid prescription issued by a practitioner from
11.3transferring the legend drug to a county or other entity that collects, stores, transports, or
11.4disposes of a legend drug pursuant to a program plan approved under section 115A.1413,
11.5or to a person authorized by one of these entities to conduct one or more of these activities.
11.6EFFECTIVE DATE.This section is effective the day following final enactment.

11.7    Sec. 4. Minnesota Statutes 2008, section 151.44, is amended to read:
11.8151.44 DEFINITIONS.
11.9As used in sections 151.43 to 151.51, the following terms have the meanings given
11.10in paragraphs (a) to (f):
11.11(a) "Wholesale drug distribution" means distribution of prescription or
11.12nonprescription drugs to persons other than a consumer or patient, or reverse distribution
11.13of such drugs, but does not include:
11.14(1) a sale between a division, subsidiary, parent, affiliated, or related company under
11.15the common ownership and control of a corporate entity;
11.16(2) the purchase or other acquisition, by a hospital or other health care entity that is a
11.17member of a group purchasing organization, of a drug for its own use from the organization
11.18or from other hospitals or health care entities that are members of such organizations;
11.19(3) the sale, purchase, or trade of a drug or an offer to sell, purchase, or trade a
11.20drug by a charitable organization described in section 501(c)(3) of the Internal Revenue
11.21Code of 1986, as amended through December 31, 1988, to a nonprofit affiliate of the
11.22organization to the extent otherwise permitted by law;
11.23(4) the sale, purchase, or trade of a drug or offer to sell, purchase, or trade a drug
11.24among hospitals or other health care entities that are under common control;
11.25(5) the sale, purchase, or trade of a drug or offer to sell, purchase, or trade a drug
11.26for emergency medical reasons;
11.27(6) the sale, purchase, or trade of a drug, an offer to sell, purchase, or trade a drug, or
11.28the dispensing of a drug pursuant to a prescription;
11.29(7) the transfer of prescription or nonprescription drugs by a retail pharmacy to
11.30another retail pharmacy to alleviate a temporary shortage;
11.31(8) the distribution of prescription or nonprescription drug samples by manufacturers
11.32representatives; or
11.33(9) the sale, purchase, or trade of blood and blood components.
12.1(b) "Wholesale drug distributor" means anyone engaged in wholesale drug
12.2distribution including, but not limited to, manufacturers; repackers; own-label distributors;
12.3jobbers; brokers; warehouses, including manufacturers' and distributors' warehouses,
12.4chain drug warehouses, and wholesale drug warehouses; independent wholesale drug
12.5traders; and pharmacies that conduct wholesale drug distribution. A wholesale drug
12.6distributor does not include a common carrier or individual hired primarily to transport
12.7prescription or nonprescription drugs.
12.8(c) "Manufacturer" means anyone who is engaged in the manufacturing, preparing,
12.9propagating, compounding, processing, packaging, repackaging, or labeling of a
12.10prescription drug.
12.11(d) "Prescription drug" means a drug required by federal or state law or regulation
12.12to be dispensed only by a prescription, including finished dosage forms and active
12.13ingredients subject to United States Code, title 21, sections 811 and 812.
12.14(e) "Blood" means whole blood collected from a single donor and processed either
12.15for transfusion or further manufacturing.
12.16(f) "Blood components" means that part of blood separated by physical or
12.17mechanical means.
12.18(g) "Reverse distribution" means the receipt of prescription or nonprescription drugs
12.19received from or shipped to Minnesota locations for the purpose of returning the drugs
12.20to their producers or distributors.
12.21(h) "Reverse distributor" means a person engaged in the reverse distribution of drugs.
12.22EFFECTIVE DATE.This section is effective the day following final enactment."
12.23Delete the title and insert:
12.25relating to solid waste; requiring drug producers to register and pay a fee;
12.26prescribing requirements for a drug collection program funded by drug producers;
12.27requiring a report; creating an account; providing penalties; expanding the
12.28categories of persons allowed to possess legend and nonprescription drugs to
12.29include those disposing of them; amending the definition of "wholesale drug
12.30distribution"; prohibiting the flushing of drugs into the sewer system by health
12.31care facilities; appropriating money;amending Minnesota Statutes 2008, sections
12.32151.37, subdivisions 6, 7; 151.44; proposing coding for new law in Minnesota
12.33Statutes, chapters 115A; 144."